RSS Feeds
Search

Articles

Pharmalicensing brings you advice, commentary and analysis from industry experts.

Articles

No results found for given criteria.
Please try to put more general criteria into your selection.

Related Reports

Market Research Reports provided by reports.iptechex.com
FDA ends the 50-year long wait for Lupus patients - Benlysta set to become the next blockbuster
Mar 2011 - 5 pages - $500
World HCV Testing, 2003 to 2007
Feb 2006 - 13 pages - $800
Epidemiology: Systemic lupus erythematosus - Systemic lupus erythematosus is a rare but debilitating autoimmune disease affecting hundreds of thousands of women of childbearing age worldwide
Mar 2011 - 34 pages - $5,700
Electrophysiology Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017
Aug 2011 - 189 pages - $2,500
Systemic Lupus Erythematosus Therapy Area Pipeline Report
Nov 2010 - 240 pages - $1,495
Cardiovascular Monitoring and Diagnostic Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017
Sep 2011 - 279 pages - $2,500
Brazil Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and Others
Oct 2011 - 206 pages - $2,500
SomaLogic, Inc. - Product Pipeline Analysis
Mar 2011 - 23 pages - $750
Italy Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and Others
Oct 2011 - 216 pages - $2,500
Lupus Nephritis - Pipeline Review, Q1 2011
Mar 2011 - 42 pages - $500
More Related Market Research Reports >>>

Your selection

Industry sector
Diagnostic del
Test systems del
Therapeutic target
Dermatological del
Lupus del
Year
2003 del

Browse By

Industry sector
Chemistry
Cytology/Histology
Hematology
Immunology
In-vivo systems
Microbiology
Other
Serology

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us